The original success of Viagra undeniably transformed the medication landscape, but investing in companies heavily reliant on off-patent versions presents a uncertain picture. Despite early returns were substantial, the end of patents and the emergence of less expensive alternatives have eroded market share. Thus, a thorough analysis of current rev